NFE2L3 and renal cell carcinoma: In our study, we discovered the elevated expression of NFE2L3 in KIRC and KIRP tissues versus normal adjacent tissues, identified NFE2L3 as one survival-relevant gene for KIRC and KIRP, and uncovered a potential regulatory role of NFE2L3 in the immune microenvironment in RCC patients.